Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm
Abstract We developed a novel computer-aided diagnosis (CAD) system that uses feature-ranking and a genetic algorithm to analyze structural magnetic resonance imaging data; using this system, we can predict conversion of mild cognitive impairment (MCI)-to-Alzheimer's disease (AD) at between one...
Gespeichert in:
Veröffentlicht in: | Computers in biology and medicine 2017-04, Vol.83, p.109-119 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 119 |
---|---|
container_issue | |
container_start_page | 109 |
container_title | Computers in biology and medicine |
container_volume | 83 |
creator | Beheshti, Iman Demirel, Hasan Matsuda, Hiroshi |
description | Abstract We developed a novel computer-aided diagnosis (CAD) system that uses feature-ranking and a genetic algorithm to analyze structural magnetic resonance imaging data; using this system, we can predict conversion of mild cognitive impairment (MCI)-to-Alzheimer's disease (AD) at between one and three years before clinical diagnosis. The CAD system was developed in four stages. First, we used a voxel-based morphometry technique to investigate global and local gray matter (GM) atrophy in an AD group compared with healthy controls (HCs). Regions with significant GM volume reduction were segmented as volumes of interest (VOIs). Second, these VOIs were used to extract voxel values from the respective atrophy regions in AD, HC, stable MCI (sMCI) and progressive MCI (pMCI) patient groups. The voxel values were then extracted into a feature vector. Third, at the feature-selection stage, all features were ranked according to their respective t-test scores and a genetic algorithm designed to find the optimal feature subset. The Fisher criterion was used as part of the objective function in the genetic algorithm. Finally, the classification was carried out using a support vector machine (SVM) with 10-fold cross validation. We evaluated the proposed automatic CAD system by applying it to baseline values from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset (160 AD, 162 HC, 65 sMCI and 71 pMCI subjects). The experimental results indicated that the proposed system is capable of distinguishing between sMCI and pMCI patients, and would be appropriate for practical use in a clinical setting. |
doi_str_mv | 10.1016/j.compbiomed.2017.02.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1874788396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0010482517300483</els_id><sourcerecordid>1885079676</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-a884a5e7811020a7c831584f2369de31ccfd4189c46e07b46519b745eae297fa3</originalsourceid><addsrcrecordid>eNqNks1u1DAUhSMEokPhFZAlFrBJsGMndjZI7YgCUiUWwNryODepp4kdbGek8nq8WG1NR0VdsbFl-Tv379yiQARXBJP2477Sbl52xs3QVzUmvMJ1hQl5VmyI4F2JG8qeFxuMCS6ZqJuz4lUIe4wxwxS_LM5qUbe4JWxT_N1OKgQzGK2icRa5AV1Mf27AzODfB9SbACoAUrZHi4fe6BM1m6lH2o3WRHMAZOZFGT-DjWV05b8htLMH8CHLBu9mFKJfdVy9mtCsRgvRaOQhuNXrHEaNxo5oDfkcQCUQkFf2Nr9zFQqNcBSpaXTexJv5dfFiUFOANw_3efHr6vPP7dfy-vuXb9uL61I3NY2lEoKpBrggBNdYcS0oaQQbatp2PVCi9dAzIjrNWsB8x9qGdDvOGlBQd3xQ9Lz4cIy7ePd7hRDlbIKGaVIW3BpkGj3jQtCuTei7J-g-NWhTdYkSDeZdyzMljpT2LgQPg1x8moC_kwTLbLTcy0ejZTZa4lomo5P07UOCdZf_TsKTswm4PAKQJnIw4GXQBqxOHnrQUfbO_E-WT0-C6MnYtCvTLdxBeOxJhiSQP_LC5X0jnKZdE5TeAx_o2B8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1885079676</pqid></control><display><type>article</type><title>Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Beheshti, Iman ; Demirel, Hasan ; Matsuda, Hiroshi</creator><creatorcontrib>Beheshti, Iman ; Demirel, Hasan ; Matsuda, Hiroshi ; for the Alzheimer's Disease Neuroimaging Initiative ; Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><description>Abstract We developed a novel computer-aided diagnosis (CAD) system that uses feature-ranking and a genetic algorithm to analyze structural magnetic resonance imaging data; using this system, we can predict conversion of mild cognitive impairment (MCI)-to-Alzheimer's disease (AD) at between one and three years before clinical diagnosis. The CAD system was developed in four stages. First, we used a voxel-based morphometry technique to investigate global and local gray matter (GM) atrophy in an AD group compared with healthy controls (HCs). Regions with significant GM volume reduction were segmented as volumes of interest (VOIs). Second, these VOIs were used to extract voxel values from the respective atrophy regions in AD, HC, stable MCI (sMCI) and progressive MCI (pMCI) patient groups. The voxel values were then extracted into a feature vector. Third, at the feature-selection stage, all features were ranked according to their respective t-test scores and a genetic algorithm designed to find the optimal feature subset. The Fisher criterion was used as part of the objective function in the genetic algorithm. Finally, the classification was carried out using a support vector machine (SVM) with 10-fold cross validation. We evaluated the proposed automatic CAD system by applying it to baseline values from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset (160 AD, 162 HC, 65 sMCI and 71 pMCI subjects). The experimental results indicated that the proposed system is capable of distinguishing between sMCI and pMCI patients, and would be appropriate for practical use in a clinical setting.</description><identifier>ISSN: 0010-4825</identifier><identifier>EISSN: 1879-0534</identifier><identifier>DOI: 10.1016/j.compbiomed.2017.02.011</identifier><identifier>PMID: 28260614</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Aged ; Aged, 80 and over ; Aging ; Algorithms ; Alzheimer Disease - diagnostic imaging ; Alzheimer Disease - etiology ; Alzheimer Disease - pathology ; Alzheimer's disease ; Atrophy ; Bioindicators ; Brain ; Brain - diagnostic imaging ; Brain - pathology ; CAD ; Classification ; Cognitive ability ; Cognitive Dysfunction - complications ; Cognitive Dysfunction - diagnostic imaging ; Cognitive Dysfunction - pathology ; Computed tomography ; Computer aided design ; Data reduction ; Datasets ; Dementia ; Dementia disorders ; Diagnosis ; Disease ; Disease Progression ; Drugs ; Early Diagnosis ; Emission measurements ; Feature ranking ; Female ; Genetic algorithm ; Genetic algorithms ; Homogeneity ; Humans ; Image Interpretation, Computer-Assisted - methods ; Impairment ; Internal Medicine ; Machine Learning ; Magnetic resonance imaging ; Magnetic Resonance Imaging - methods ; Male ; Medical imaging ; Middle Aged ; Mild cognitive impairment conversion ; Morphometry ; Neurodegenerative diseases ; Neuroimaging ; Other ; Pattern Recognition, Automated - methods ; Principal components analysis ; Prognosis ; Quality of life ; Ranking ; Reproducibility of Results ; Resonance ; Sensitivity and Specificity ; Substantia grisea ; Support vector machines ; Tomography</subject><ispartof>Computers in biology and medicine, 2017-04, Vol.83, p.109-119</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Apr 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-a884a5e7811020a7c831584f2369de31ccfd4189c46e07b46519b745eae297fa3</citedby><cites>FETCH-LOGICAL-c523t-a884a5e7811020a7c831584f2369de31ccfd4189c46e07b46519b745eae297fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0010482517300483$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28260614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Beheshti, Iman</creatorcontrib><creatorcontrib>Demirel, Hasan</creatorcontrib><creatorcontrib>Matsuda, Hiroshi</creatorcontrib><creatorcontrib>for the Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><creatorcontrib>Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><title>Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm</title><title>Computers in biology and medicine</title><addtitle>Comput Biol Med</addtitle><description>Abstract We developed a novel computer-aided diagnosis (CAD) system that uses feature-ranking and a genetic algorithm to analyze structural magnetic resonance imaging data; using this system, we can predict conversion of mild cognitive impairment (MCI)-to-Alzheimer's disease (AD) at between one and three years before clinical diagnosis. The CAD system was developed in four stages. First, we used a voxel-based morphometry technique to investigate global and local gray matter (GM) atrophy in an AD group compared with healthy controls (HCs). Regions with significant GM volume reduction were segmented as volumes of interest (VOIs). Second, these VOIs were used to extract voxel values from the respective atrophy regions in AD, HC, stable MCI (sMCI) and progressive MCI (pMCI) patient groups. The voxel values were then extracted into a feature vector. Third, at the feature-selection stage, all features were ranked according to their respective t-test scores and a genetic algorithm designed to find the optimal feature subset. The Fisher criterion was used as part of the objective function in the genetic algorithm. Finally, the classification was carried out using a support vector machine (SVM) with 10-fold cross validation. We evaluated the proposed automatic CAD system by applying it to baseline values from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset (160 AD, 162 HC, 65 sMCI and 71 pMCI subjects). The experimental results indicated that the proposed system is capable of distinguishing between sMCI and pMCI patients, and would be appropriate for practical use in a clinical setting.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging</subject><subject>Algorithms</subject><subject>Alzheimer Disease - diagnostic imaging</subject><subject>Alzheimer Disease - etiology</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Atrophy</subject><subject>Bioindicators</subject><subject>Brain</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - pathology</subject><subject>CAD</subject><subject>Classification</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - complications</subject><subject>Cognitive Dysfunction - diagnostic imaging</subject><subject>Cognitive Dysfunction - pathology</subject><subject>Computed tomography</subject><subject>Computer aided design</subject><subject>Data reduction</subject><subject>Datasets</subject><subject>Dementia</subject><subject>Dementia disorders</subject><subject>Diagnosis</subject><subject>Disease</subject><subject>Disease Progression</subject><subject>Drugs</subject><subject>Early Diagnosis</subject><subject>Emission measurements</subject><subject>Feature ranking</subject><subject>Female</subject><subject>Genetic algorithm</subject><subject>Genetic algorithms</subject><subject>Homogeneity</subject><subject>Humans</subject><subject>Image Interpretation, Computer-Assisted - methods</subject><subject>Impairment</subject><subject>Internal Medicine</subject><subject>Machine Learning</subject><subject>Magnetic resonance imaging</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Middle Aged</subject><subject>Mild cognitive impairment conversion</subject><subject>Morphometry</subject><subject>Neurodegenerative diseases</subject><subject>Neuroimaging</subject><subject>Other</subject><subject>Pattern Recognition, Automated - methods</subject><subject>Principal components analysis</subject><subject>Prognosis</subject><subject>Quality of life</subject><subject>Ranking</subject><subject>Reproducibility of Results</subject><subject>Resonance</subject><subject>Sensitivity and Specificity</subject><subject>Substantia grisea</subject><subject>Support vector machines</subject><subject>Tomography</subject><issn>0010-4825</issn><issn>1879-0534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNks1u1DAUhSMEokPhFZAlFrBJsGMndjZI7YgCUiUWwNryODepp4kdbGek8nq8WG1NR0VdsbFl-Tv379yiQARXBJP2477Sbl52xs3QVzUmvMJ1hQl5VmyI4F2JG8qeFxuMCS6ZqJuz4lUIe4wxwxS_LM5qUbe4JWxT_N1OKgQzGK2icRa5AV1Mf27AzODfB9SbACoAUrZHi4fe6BM1m6lH2o3WRHMAZOZFGT-DjWV05b8htLMH8CHLBu9mFKJfdVy9mtCsRgvRaOQhuNXrHEaNxo5oDfkcQCUQkFf2Nr9zFQqNcBSpaXTexJv5dfFiUFOANw_3efHr6vPP7dfy-vuXb9uL61I3NY2lEoKpBrggBNdYcS0oaQQbatp2PVCi9dAzIjrNWsB8x9qGdDvOGlBQd3xQ9Lz4cIy7ePd7hRDlbIKGaVIW3BpkGj3jQtCuTei7J-g-NWhTdYkSDeZdyzMljpT2LgQPg1x8moC_kwTLbLTcy0ejZTZa4lomo5P07UOCdZf_TsKTswm4PAKQJnIw4GXQBqxOHnrQUfbO_E-WT0-C6MnYtCvTLdxBeOxJhiSQP_LC5X0jnKZdE5TeAx_o2B8</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Beheshti, Iman</creator><creator>Demirel, Hasan</creator><creator>Matsuda, Hiroshi</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AL</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0N</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20170401</creationdate><title>Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm</title><author>Beheshti, Iman ; Demirel, Hasan ; Matsuda, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-a884a5e7811020a7c831584f2369de31ccfd4189c46e07b46519b745eae297fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging</topic><topic>Algorithms</topic><topic>Alzheimer Disease - diagnostic imaging</topic><topic>Alzheimer Disease - etiology</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Atrophy</topic><topic>Bioindicators</topic><topic>Brain</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - pathology</topic><topic>CAD</topic><topic>Classification</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - complications</topic><topic>Cognitive Dysfunction - diagnostic imaging</topic><topic>Cognitive Dysfunction - pathology</topic><topic>Computed tomography</topic><topic>Computer aided design</topic><topic>Data reduction</topic><topic>Datasets</topic><topic>Dementia</topic><topic>Dementia disorders</topic><topic>Diagnosis</topic><topic>Disease</topic><topic>Disease Progression</topic><topic>Drugs</topic><topic>Early Diagnosis</topic><topic>Emission measurements</topic><topic>Feature ranking</topic><topic>Female</topic><topic>Genetic algorithm</topic><topic>Genetic algorithms</topic><topic>Homogeneity</topic><topic>Humans</topic><topic>Image Interpretation, Computer-Assisted - methods</topic><topic>Impairment</topic><topic>Internal Medicine</topic><topic>Machine Learning</topic><topic>Magnetic resonance imaging</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Middle Aged</topic><topic>Mild cognitive impairment conversion</topic><topic>Morphometry</topic><topic>Neurodegenerative diseases</topic><topic>Neuroimaging</topic><topic>Other</topic><topic>Pattern Recognition, Automated - methods</topic><topic>Principal components analysis</topic><topic>Prognosis</topic><topic>Quality of life</topic><topic>Ranking</topic><topic>Reproducibility of Results</topic><topic>Resonance</topic><topic>Sensitivity and Specificity</topic><topic>Substantia grisea</topic><topic>Support vector machines</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Beheshti, Iman</creatorcontrib><creatorcontrib>Demirel, Hasan</creatorcontrib><creatorcontrib>Matsuda, Hiroshi</creatorcontrib><creatorcontrib>for the Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><creatorcontrib>Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Computing Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Computing Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Computers in biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beheshti, Iman</au><au>Demirel, Hasan</au><au>Matsuda, Hiroshi</au><aucorp>for the Alzheimer's Disease Neuroimaging Initiative</aucorp><aucorp>Alzheimer's Disease Neuroimaging Initiative</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm</atitle><jtitle>Computers in biology and medicine</jtitle><addtitle>Comput Biol Med</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>83</volume><spage>109</spage><epage>119</epage><pages>109-119</pages><issn>0010-4825</issn><eissn>1879-0534</eissn><abstract>Abstract We developed a novel computer-aided diagnosis (CAD) system that uses feature-ranking and a genetic algorithm to analyze structural magnetic resonance imaging data; using this system, we can predict conversion of mild cognitive impairment (MCI)-to-Alzheimer's disease (AD) at between one and three years before clinical diagnosis. The CAD system was developed in four stages. First, we used a voxel-based morphometry technique to investigate global and local gray matter (GM) atrophy in an AD group compared with healthy controls (HCs). Regions with significant GM volume reduction were segmented as volumes of interest (VOIs). Second, these VOIs were used to extract voxel values from the respective atrophy regions in AD, HC, stable MCI (sMCI) and progressive MCI (pMCI) patient groups. The voxel values were then extracted into a feature vector. Third, at the feature-selection stage, all features were ranked according to their respective t-test scores and a genetic algorithm designed to find the optimal feature subset. The Fisher criterion was used as part of the objective function in the genetic algorithm. Finally, the classification was carried out using a support vector machine (SVM) with 10-fold cross validation. We evaluated the proposed automatic CAD system by applying it to baseline values from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset (160 AD, 162 HC, 65 sMCI and 71 pMCI subjects). The experimental results indicated that the proposed system is capable of distinguishing between sMCI and pMCI patients, and would be appropriate for practical use in a clinical setting.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>28260614</pmid><doi>10.1016/j.compbiomed.2017.02.011</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0010-4825 |
ispartof | Computers in biology and medicine, 2017-04, Vol.83, p.109-119 |
issn | 0010-4825 1879-0534 |
language | eng |
recordid | cdi_proquest_miscellaneous_1874788396 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Aged Aged, 80 and over Aging Algorithms Alzheimer Disease - diagnostic imaging Alzheimer Disease - etiology Alzheimer Disease - pathology Alzheimer's disease Atrophy Bioindicators Brain Brain - diagnostic imaging Brain - pathology CAD Classification Cognitive ability Cognitive Dysfunction - complications Cognitive Dysfunction - diagnostic imaging Cognitive Dysfunction - pathology Computed tomography Computer aided design Data reduction Datasets Dementia Dementia disorders Diagnosis Disease Disease Progression Drugs Early Diagnosis Emission measurements Feature ranking Female Genetic algorithm Genetic algorithms Homogeneity Humans Image Interpretation, Computer-Assisted - methods Impairment Internal Medicine Machine Learning Magnetic resonance imaging Magnetic Resonance Imaging - methods Male Medical imaging Middle Aged Mild cognitive impairment conversion Morphometry Neurodegenerative diseases Neuroimaging Other Pattern Recognition, Automated - methods Principal components analysis Prognosis Quality of life Ranking Reproducibility of Results Resonance Sensitivity and Specificity Substantia grisea Support vector machines Tomography |
title | Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T15%3A50%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Classification%20of%20Alzheimer's%20disease%20and%20prediction%20of%20mild%20cognitive%20impairment-to-Alzheimer's%20conversion%20from%20structural%20magnetic%20resource%20imaging%20using%20feature%20ranking%20and%20a%20genetic%20algorithm&rft.jtitle=Computers%20in%20biology%20and%20medicine&rft.au=Beheshti,%20Iman&rft.aucorp=for%20the%20Alzheimer's%20Disease%20Neuroimaging%20Initiative&rft.date=2017-04-01&rft.volume=83&rft.spage=109&rft.epage=119&rft.pages=109-119&rft.issn=0010-4825&rft.eissn=1879-0534&rft_id=info:doi/10.1016/j.compbiomed.2017.02.011&rft_dat=%3Cproquest_cross%3E1885079676%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1885079676&rft_id=info:pmid/28260614&rft_els_id=1_s2_0_S0010482517300483&rfr_iscdi=true |